O
MRNA icon

Ossiam’s Moderna MRNA Stock Holding History

Ossiam’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857K Sell
12,237
-544
-4% -$28.1K 0.01% 432
2026
Q1 		$649K Sell
12,781
-48,993
-79% -$2.29M 0.01% 266
2025
Q4 		$1.82M Buy
61,774
+16,865
+38% +$458K 0.04% 159
2025
Q3 		$1.16M Sell
44,909
-66,527
-60% -$1.86M 0.01% 438
2025
Q2 		$3.07M Buy
111,436
+99,641
+845% +$2.62M 0.03% 214
2025
Q1 		$334K Sell
11,795
-2,779
-19% -$98.6K ﹤0.01% 462
2024
Q4 		$606K Buy
14,574
+799
+6% +$38.2K 0.01% 432
2024
Q3 		$921K Sell
13,775
-6,016
-30% -$552K 0.02% 361
2024
Q2 		$2.35M Buy
19,791
+989
+5% +$125K 0.04% 190
2024
Q1 		$2M Buy
18,802
+5,145
+38% +$519K 0.04% 247
2023
Q4 		$1.36M Buy
13,657
+55
+0.4% +$4.63K 0.02% 302
2023
Q3 		$1.4M Buy
13,602
+8
+0.1% +$892 0.02% 281
2023
Q2 		$1.65M Sell
13,594
-1,347
-9% -$180K 0.03% 231
2023
Q1 		$2.29M Sell
14,941
-2,579
-15% -$425K 0.05% 192
2022
Q4 		$3.15M Buy
17,520
+12,486
+248% +$2.04M 0.08% 157
2022
Q3 		$595K Buy
5,034
+1,811
+56% +$275K 0.02% 351
2022
Q2 		$460K Buy
+3,223
New +$461K 0.01% 323
2022
Q1 		– Sell
-769
Closed -$195K – 464
2021
Q4 		$195K Sell
769
-16,566
-96% -$4.84M 0.01% 367
2021
Q3 		$6.67M Buy
+17,335
New +$6.39M 0.19% 92

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Ossiam's MRNA Position: Q2 2026 in Review

Ossiam reduced its Moderna (MRNA) stake by 4.3% in Q2 2026, selling an estimated $28.1K and leaving 12,237 shares worth $857K. The position accounts for 0.01% of the portfolio, ranked #432.

Ossiam first reported a position in MRNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $6.67M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Ossiam held 12,237 shares of Moderna worth $857K as of Q2 2026.
  • Ossiam sold 544 Moderna shares in Q2 2026, an estimated $28.1K.
  • Moderna made up 0.01% of Ossiam's portfolio in Q2 2026, its #432 holding.
  • Ossiam first reported a position in Moderna in Q3 2021 and has held it in 19 quarters since.
  • Ossiam's Moderna position peaked at $6.67M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.